What happens when you take famotidine with vitamin b12?
Famotidine (Pepcid) is a histamine H2-receptor antagonist. It blocks H2 receptors on gastric parietal cells, which reduces histamine-stimulated acid secretion. Unlike PPIs, which shut down the final-common acid pump and reduce acid output by 90% or more, H2 blockers reduce acid output by about 60-70% and the effect tends to attenuate over time as tolerance develops.
Despite the smaller magnitude, the mechanism of interference with B12 is the same as PPIs. Dietary B12 is bound to animal proteins and requires gastric acid and pepsin to be liberated before it can bind to intrinsic factor and be absorbed in the terminal ileum. Reducing acid output by even 60% impairs that liberation step. With long-term famotidine use, particularly in older adults who already have age-related declines in gastric acid, food-bound B12 absorption can drop enough to cause deficiency.
Crystalline (supplemental) B12 is not affected. Cyanocobalamin or methylcobalamin in pills, sublingual tablets, or injections does not need stomach acid for absorption because it is already free of food protein.
Why is this important?
A landmark 2013 JAMA case-control study by Lam et al. found that H2-receptor antagonist use of 2 or more years was associated with a 25% increased odds of newly diagnosed vitamin B12 deficiency (PPIs were higher at 65%). The risk was dose-dependent. While the absolute risk for any individual is small, famotidine is widely used over the counter and prescribed long-term for reflux, ulcer prophylaxis, and as an adjunct in patients with mast cell disorders, so the population impact is meaningful.
B12 deficiency develops slowly because liver stores last 2-5 years. The early signs are subtle: fatigue, brain fog, glossitis, mild peripheral tingling. As deficiency progresses, megaloblastic anemia develops, and neurologic damage (peripheral neuropathy, proprioceptive loss, balance problems, dementia, subacute combined degeneration of the spinal cord) can become partially irreversible.
Higher-risk groups on famotidine include: adults over 65, vegetarians and vegans (lower dietary intake), patients also on metformin (independently lowers B12), patients with autoimmune or H. pylori atrophic gastritis, and post-bariatric surgery patients.
What should you do?
- Annual B12 check after 2 years. If serum B12 is below 300 pg/mL or you have symptoms, request a methylmalonic acid (MMA) test. MMA is more sensitive for early deficiency.
- Supplement with crystalline B12. 500-1000 mcg oral or sublingual cyanocobalamin or methylcobalamin daily covers most people. Since supplemental B12 does not need stomach acid, the famotidine interaction does not affect it.
- Injectable B12 for severe cases. 1000 mcg IM weekly for 4-8 weeks then monthly is standard for symptomatic deficiency.
- Reassess your indication. OTC famotidine for occasional heartburn is fine. Daily long-term use should have a clear ongoing indication; talk to your doctor about whether on-demand use suffices.
- Watch for symptoms. Unexplained fatigue, peripheral tingling, balance issues, or cognitive fog in a long-term famotidine user warrants B12 testing.
- Combine with other risk factors thoughtfully. If you also take metformin, are vegetarian or vegan, or are over 65, your overall B12 risk is higher and supplementation is cheap insurance.
Which specific products are affected?
Famotidine is sold as Pepcid AC (OTC 10 mg and 20 mg), Pepcid Complete (with calcium carbonate and magnesium hydroxide), and generic famotidine in OTC and prescription strengths (20 mg, 40 mg). All forms share the acid-suppressing effect.
Other H2 blockers carry the same interaction: cimetidine (Tagamet), nizatidine (Axid), and the previously available ranitidine (Zantac, withdrawn in 2020 due to NDMA contamination). Cimetidine is the strongest of this class for acid suppression and also has many drug-drug CYP interactions.
On the supplement side, crystalline B12 in any form works around the interaction: cyanocobalamin (cheapest, well-studied), methylcobalamin (active form), hydroxocobalamin (long-acting injection), adenosylcobalamin (mitochondrial form). Fortified foods (cereals, plant milks, nutritional yeast) typically use cyanocobalamin and absorb similarly to supplements.
The bottom line
Famotidine reduces stomach acid by about 60-70%, which is less than PPIs but still enough to impair food-bound B12 absorption with chronic use. Studies show a smaller but real increase in B12 deficiency risk after 2 or more years of H2 blocker use. The mitigation is simple: get serum B12 checked periodically after 2 years, and supplement with 500-1000 mcg oral or sublingual crystalline B12 daily if levels are low. Supplemental B12 does not need stomach acid, so the famotidine interaction does not affect it. If your reflux is well-controlled and your indication is unclear, talk to your doctor about whether daily use is still needed or whether on-demand dosing would work.